Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. Amylyx Pharmaceuticals is considering voluntarily withdrawing the drug, Relyvrio/Albrioza, after it failed to help patients in a large follow-up study. The company has decided to pause promotion of the medication and will announce their plans for the drug in the next two months.
Following disappointing trial results , the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just short of saying it will definitely pull the drug from the market. The drug is sold as Albrioza in Canada.
"Amylyx intends to share plans for Relyvrio/Albrioza in ALS, which may include voluntarily withdrawing Relyvrio/Albrioza from the market," the company said in its statement. "At this time, Relyvrio/Albrioza and its related patient support program will continue to be available for people living with ALS. Amylyx has voluntarily decided to pause promotion of the medication during this time." Executives added that they were “surprised and disappointed” by the results and would announce their plans for the drug in the next two months. Relyvrio was first approved by the U.S. Food and Drug Administration in September 2022, following a lengthy, impassioned campaign by patients with ALS, a fatal muscle-wasting diseas
ALS Drug Medication Market Trial Results Amylyx Pharmaceuticals Relyvrio Albrioza Patients Study
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Amylyx May Pull FDA-Approved ALS Drug After Failed Phase 3 TrialTopline results for the ALS drug Relyvrio show that it failed to meet primary or secondary endpoints. The company says it may voluntarily pull the drug from the market.
Read more »
Controversial ‘Clean Energy Bill’ drops ban on natural gas, may face challengeGov. Jay Inslee will be facing a hard decision, whether to sign the 'Clean Energy Bill' that aims to transform the state's biggest utility.
Read more »
Feds: Drug trafficker 'executed' 2 witnesses, including pregnant mother, in San Diego-based drug prosecutionsAuthorities allege Benjamin Madrigal-Birrueta and at least one co-conspirator murdered the two witnesses and buried them in a desert grave in central Washington state
Read more »
Drug That Treats Cocaine Addiction May Curb Colon CancerA drug first developed to treat cocaine addiction might also help slow the spread of advanced colon cancer, a new study suggests.
Read more »
Recent gaffes by Biden and Trump may be signs of normal aging — or may be nothingPresident Biden and former President Trump have both experienced public memory lapses. But brain experts say such slips, on their own, are not a cause for concern.
Read more »